TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2017

Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Elisa V Gomez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.